Bronchial artery embolisation in management of XXXX - A retrospective analysis in a tertiary university hospital.

@entity1 @entity1184 @entity4595 @entity378 @entity5492 @entity1577
BACKGROUND: Bronchial artery embolisation (BAE) becomes a mainstay in the treatment of @entity5492 . OBJECTIVE: To characterise @entity1 with @entity5492 undergoing bronchial artery angiography (BAA) for embolisation, evaluating outcomes. METHODS: We retrospectively evaluated @entity1 with acute severe or chronic recurrent @entity5492 admitted to the Pulmonology department and submitted to BAA for purpose of embolisation. RESULTS: A total of 88 @entity1 were submitted to BAA, 47 (53.4%) were male, with a mean age of 61.4  15.8 years. In 64 (72.7%) @entity1 , @entity5492 presented as chronic recurrent episodes. @entity5492 was considered severe in 40 (45.5%) @entity1 . @entity4595 (other than @entity1577 ) (n=35; 38.0%) and @entity378 sequelae (n=31; 35.2) were the major aetiology for @entity5492 . The main angiographic abnormality was @entity1184 and tortuosity (n=68; 77.3%). BAE was performed in 67 (76.1%) of the 88 @entity1 submitted to BAA. Immediate success was achieved in 66 (98.5%) @entity1 . Recurrence of @entity5492 occurred in 25 (37.3%) @entity1 , and was related to presence of shunting (p=0.049). The procedure-related complications were self-limited. CONCLUSION: Our results suggest that BAE is a safe and effective treatment for acute severe and chronic recurrent @entity5492 , supporting the current literature. Besides this, bleeding recurrence was relatively high, and correlated with presence of systemic pulmonary shunting.
